Isoniazid preventive therapy and risk for resistant tuberculosis (Q36029457)

11 August 2017

5 references

23 March 2019

22 June 2019

2 November 2019

7 November 2019

17 January 2024

0 references

Isoniazid preventive therapy and risk for resistant tuberculosis (English)

1 reference

11 August 2017

2 references

2 November 2019

7 November 2019

1 reference

2 November 2019

1 reference

7 November 2019

0 references

Peter Godfrey-Faussett

3

object named as

Peter Godfrey-Faussett

1 reference

11 August 2017

Maria Elvira Balcells

1

1 reference

11 August 2017

Sara L Thomas

2

1 reference

11 August 2017

Alison D Grant

4

1 reference

11 August 2017

language of work or name

1 reference

1 May 2006

6 references

Emerging Infectious Diseases

11 August 2017

23 March 2019

22 June 2019

2 November 2019

7 November 2019

17 January 2024

6 references

11 August 2017

23 March 2019

22 June 2019

2 November 2019

7 November 2019

17 January 2024

12

1 reference

11 August 2017

5

1 reference

11 August 2017

744-751

1 reference

Treatment of latent tuberculosis infection in HIV infected persons

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

M. tuberculosis persistence, latency, and drug tolerance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Operating characteristics of a rank correlation test for publication bias

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Effects of chemoprophylaxis on minimal pulmonary tuberculosis lesions of doubtful activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Controlled chemoprophylaxis trials in tuberculosis. A general review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Meta-analysis in clinical trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Nosocomial epidemic of active tuberculosis among HIV-infected patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374455

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

23 September 2018

1 reference

12 December 2020

A controlled trial of community-wide isoniazid prophylaxis in Alaska

1 reference

12 December 2020

The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions

1 reference

12 December 2020

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

12 December 2020

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

12 December 2020

Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts

1 reference

12 December 2020

EFFECT OF ISONIAZID UPON THE REACTIVATION OF INACTIVE TUBERCULOSIS; FINAL REPORT

1 reference

12 December 2020

Identifiers

DOI

10.3201/EID1205.050681

1 reference

11 August 2017

1 reference

11 August 2017

1 reference